“The rating reflects our assessment of Halifax’s healthy balance of days’ cash on hand, dominant market position, strong non-operating activity and positive demographic trends within its service area and encouraging economic growth,” said S&P credit analyst Patrick Zagar.
The outlook is stable.
S&P has also affirmed the “A-” long-term rating on Halifax Health’s outstanding series 2006A and series 2015 bonds.
More articles on healthcare finance:
Aurora HealthCare taps Strata Decision for financial analytics
Rhode Island hospital scales back services to stem losses|
Lahey Health’s flagship hospital takes financial hit from Epic transition
